Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.75 USD | -4.32% | -3.85% | +54.38% |
Financials (USD)
Sales 2024 * | 108M | Sales 2025 * | 277M | Capitalization | 5.36B |
---|---|---|---|---|---|
Net income 2024 * | -437M | Net income 2025 * | -307M | EV / Sales 2024 * | 49.7 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 19.3 x |
P/E ratio 2024 * |
-9.23
x | P/E ratio 2025 * |
-15.3
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 22.2% |
Latest transcript on ImmunityBio, Inc.
1 day | -4.32% | ||
1 week | -3.85% | ||
Current month | -3.00% | ||
1 month | +57.52% | ||
3 months | +59.79% | ||
6 months | +89.49% | ||
Current year | +54.38% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-23 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% | ||
0.02% | 1,487 M€ | +9.08% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 7.75 | -4.32% | 4,874,075 |
24-05-15 | 8.1 | -3.57% | 4,694,768 |
24-05-14 | 8.4 | -2.67% | 6,866,991 |
24-05-13 | 8.63 | +6.28% | 6,184,298 |
24-05-10 | 8.12 | +0.74% | 4,112,241 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+54.38% | 5.36B | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- IBRX Stock